Home › Osteoarthritis › NCT07630896
Post-op Prednisone and Glucose Monitoring in TKA
RecruitingPhase 4
Postoperative Prednisone Regimen in TKA and Its Effect on Continuous Glucose Levels
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Undergoing Primary Unicompartmental Knee Arthroplasty or Total Hip Arthroplasty * Age 18 and above Exclusion Criteria: * Steroid therapy * Narcotic use within past 3 months * History of corticosteroid intolerance * Pregnancy * Uncontrolled diabetes * Doesn't own smart phone Drop Criteria: \- 2nd dose of IV dexamethasone
About the study
This study compares the efficacy of a 5-day post-operative oral prednisone regimen (40 mg daily) with the standard intraoperative steroid regimen, focusing on pain, swelling, range of motion, opioid use, and glucose levels monitored continuously.
What is being tested
- Prednisone (drug)
- Continuous Glucose Monitor (device)
- InkWell Health Tattoos (other)
Sponsor: Columbia University · Participants: 104 · Started: Jun 22, 2026
Contact the study team
- Jacqueline Lenahan · Phone: (212) 305-8193
Official record on ClinicalTrials.gov — NCT07630896
Locations in the U.S.
| New York | Columbia University Irving Medical Center, New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.